Literature DB >> 8373556

Sexual differences in sensitivity to methamphetamine toxicity.

G C Wagner1, T L Tekirian, C T Cheo.   

Abstract

Male and female mice were treated with methamphetamine (10.0 mg/kg/injection for four injections) and sacrificed two weeks later. It was observed that the methamphetamine treatment caused depletions in striatal dopamine which were significantly greater in males (74%) than in females (56%). These results indicate that estrogen may have a protective effect against methamphetamine-induced dopamine depletions and may relate to the fact that males are more likely to incur Parkinson's disease than females.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8373556     DOI: 10.1007/bf01244939

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  10 in total

1.  The effects of deprenyl on methamphetamine-induced dopamine depletions.

Authors:  S K Johnson; D Medina; G C Wagner
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  Evaluation of the effects of inhibition of monoamine oxidase and senescence on methamphetamine-induced neuronal damage.

Authors:  G C Wagner; S L Walsh
Journal:  Int J Dev Neurosci       Date:  1991       Impact factor: 2.457

3.  Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.

Authors:  L S Seiden; G Vosmer
Journal:  Pharmacol Biochem Behav       Date:  1984-07       Impact factor: 3.533

4.  Methamphetamine-induced neuronal damage: a possible role for free radicals.

Authors:  M J De Vito; G C Wagner
Journal:  Neuropharmacology       Date:  1989-10       Impact factor: 5.250

5.  Two decades of increasing mortality from Parkinson's disease among the US elderly.

Authors:  D E Lilienfeld; E Chan; J Ehland; J Godbold; P J Landrigan; G Marsh; D P Perl
Journal:  Arch Neurol       Date:  1990-07

6.  Sex differences in the amphetamine stimulated release of catecholamines from rat striatal tissue in vitro.

Authors:  J B Becker; V D Ramirez
Journal:  Brain Res       Date:  1981-01-12       Impact factor: 3.252

7.  Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine.

Authors:  G C Wagner; G A Ricaurte; L S Seiden; C R Schuster; R J Miller; J Westley
Journal:  Brain Res       Date:  1980-01-06       Impact factor: 3.252

8.  Direct effect of 17 beta-estradiol on striatum: sex differences in dopamine release.

Authors:  J B Becker
Journal:  Synapse       Date:  1990       Impact factor: 2.562

9.  Methamphetamine-induced changes in brain catecholamines in rats and guinea pigs.

Authors:  G C Wagner; L S Seiden; C R Schuster
Journal:  Drug Alcohol Depend       Date:  1979-09       Impact factor: 4.492

10.  The oestrous cycle and monoamine oxidase activity.

Authors:  M Holzbauer; M B Youdim
Journal:  Br J Pharmacol       Date:  1973-08       Impact factor: 8.739

  10 in total
  20 in total

Review 1.  Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease.

Authors:  Michel Cyr; Frederic Calon; Marc Morissette; Thérèse Di Paolo
Journal:  J Psychiatry Neurosci       Date:  2002-01       Impact factor: 6.186

Review 2.  Estrogen as neuroprotectant of nigrostriatal dopaminergic system: laboratory and clinical studies.

Authors:  Dean Dluzen; Martin Horstink
Journal:  Endocrine       Date:  2003-06       Impact factor: 3.633

3.  The impact of clinical and demographic variables on cognitive performance in methamphetamine-dependent individuals in rural South Carolina.

Authors:  Kimber L Price; Stacia M DeSantis; Annie N Simpson; Bryan K Tolliver; Aimee L McRae-Clark; Michael E Saladin; Nathaniel L Baker; Mark T Wagner; Kathleen T Brady
Journal:  Am J Addict       Date:  2011-07-18

4.  Gender, brain-derived neurotrophic factor Val66Met, and frequency of methamphetamine use.

Authors:  Keith G Heinzerling; Steven Shoptaw
Journal:  Gend Med       Date:  2012-03-23

5.  The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats.

Authors:  B J Gehrke; S B Harrod; W A Cass; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  2003-02-13       Impact factor: 4.530

6.  Sex differences in the acquisition of IV methamphetamine self-administration and subsequent maintenance under a progressive ratio schedule in rats.

Authors:  Megan E Roth; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2003-12-04       Impact factor: 4.530

7.  Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system.

Authors:  D E Dluzen; J L McDermott; L I Anderson
Journal:  Neurotox Res       Date:  2001-07       Impact factor: 3.911

8.  PI3 kinase/Akt activation mediates estrogen and IGF-1 nigral DA neuronal neuroprotection against a unilateral rat model of Parkinson's disease.

Authors:  Arnulfo Quesada; Becky Y Lee; Paul E Micevych
Journal:  Dev Neurobiol       Date:  2008-04       Impact factor: 3.964

9.  Sex-Dependent Changes in Striatal Dopamine Transport in Preadolescent Rats Exposed Prenatally and/or Postnatally to Methamphetamine.

Authors:  Jana Sirova; Zdenka Kristofikova; Monika Vrajova; Michaela Fujakova-Lipski; Daniela Ripova; Jan Klaschka; Romana Slamberova
Journal:  Neurochem Res       Date:  2016-04-01       Impact factor: 3.996

10.  Sex differences in striatal dopaminergic function within heterozygous mutant dopamine transporter knock-out mice.

Authors:  Jing Ji; Dean E Dluzen
Journal:  J Neural Transm (Vienna)       Date:  2008-01-15       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.